NABPLAGEM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NABPLAGEM, covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer [Phase 2, Phase 3]